AMPLICEL is the first laboratory approved by the Spanish Agency of drug and health products (Competent Authority) for the manufacturing of drugs for human use in consolidated advanced therapies (chondrocytes) or for research (myoblasts) (Registration No.: E6396).
The laboratory Amplicel Cell Therapy is located in the Clinical CEMTRO of Madrid. This is where Amplicel contributes its research pertaining to cell therapy of orthopedic diseases.
AMPLICEL is also a Contract Research Organization (CRO) specializing in the analysis of nucleic acids by quantitative real time PCR. AMPLICEL has been awarded by the Comunidad de Madrid with the Good Laboratory Practices (GLP) for the analysis of the levels of drugs and their metabolites in biological samples
Amplicel is also a Contract Research Organization or CRO, specializing in the analysis of nucleic acids by quantitative real time PCR. Amplicel has been awarded by the certificate of Good Laboratory Practice issued by the Community of Madrid. This allows Amplicel to participate as a pre-clinical CRO by analyzing biological samples using this technique: Testing of biodistribution, toxicity, pharmacokinetics, etc... of pharmaceuticals in preclinical phase.
+34 91 804 62 40
+34 617 30 39 74
+34 626 19 50 50
+34 637 59 73 28
Av. Ventisquero de la Condesa, 42
A space for research and development